Oruka Therapeutics, Inc. — 425 Filings
47 425 filings on record
This page lists all 425 filings submitted to the SEC by Oruka Therapeutics, Inc. (ORKA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Oruka Therapeutics, Inc. has filed 47 425 documents with the SEC since 2008. To view all SEC filings by Oruka Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 425 | CURRENT REPORT | 0001213900-24-072685 | Aug 27, 2024 | — |
| 425 | CURRENT REPORT | 0001213900-24-070266 | Aug 16, 2024 | — |
| 425 | CURRENT REPORT | 0001213900-24-069667 | Aug 15, 2024 | — |
| 425 | FORM 425 | 0001213900-24-066829 | Aug 9, 2024 | — |
| 425 | 425 | 0000950170-24-089337 | Aug 1, 2024 | — |
| 425 | CURRENT REPORT | 0001213900-24-060159 | Jul 9, 2024 | — |
| 425 | FORM 425 | 0001213900-24-050402 | Jun 6, 2024 | — |
| 425 | 425 | 0000950170-24-048369 | Apr 25, 2024 | — |
| 425 | 425 | 0001193125-24-085440 | Apr 3, 2024 | — |
| 425 | FORM 8-K | 0001193125-09-011460 | Jan 27, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-010477 | Jan 23, 2009 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-09-006270 | Jan 15, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-005297 | Jan 13, 2009 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-09-004942 | Jan 13, 2009 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-09-003085 | Jan 8, 2009 | — |
| 425 | FORM 8-K | 0001193125-09-002751 | Jan 8, 2009 | — |
| 425 | FORM 8-K | 0001193125-08-262015 | Dec 31, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-251119 | Dec 10, 2008 | — |
| 425 | FORM 8-K | 0001193125-08-245938 | Dec 1, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-245785 | Dec 1, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-238536 | Nov 18, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-234147 | Nov 13, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-227917 | Nov 6, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-221589 | Oct 31, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-220449 | Oct 30, 2008 | — |
| 425 | FORM 8-K | 0001193125-08-218179 | Oct 29, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-215122 | Oct 23, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-207927 | Oct 8, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-206671 | Oct 6, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-205274 | Oct 2, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-203993 | Sep 30, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-203992 | Sep 30, 2008 | — |
| 425 | FORM 8-K | 0001193125-08-201336 | Sep 25, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-201370 | Sep 25, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-201361 | Sep 25, 2008 | — |
| 425 | FILED PURSUANT TO RULE 425 | 0001193125-08-201354 | Sep 25, 2008 | — |
| 425 | FORM 425 | 0000950149-03-000163 | Jan 28, 2003 | — |
| 425 | FORM 425 | 0000891618-03-000174 | Jan 21, 2003 | — |
| 425 | FORM 425 | 0000891618-03-000173 | Jan 21, 2003 | — |
| 425 | FORM 425 | 0000891618-03-000057 | Jan 7, 2003 | — |
| 425 | FORM 425 | 0000891618-02-005572 | Dec 19, 2002 | — |
| 425 | FORM 425 | 0000891618-02-005538 | Dec 17, 2002 | — |
| 425 | HYSEQ, INC. FORM 425 | 0000891618-02-005105 | Nov 13, 2002 | — |
| 425 | FORM 425 | 0000891618-02-005003 | Nov 12, 2002 | — |
| 425 | FORM 425 | 0000891618-02-005002 | Nov 12, 2002 | — |
| 425 | FORM 425 | 0000891618-02-005001 | Nov 12, 2002 | — |
| 425 | FORM 425 | 0000891618-02-005000 | Nov 12, 2002 | — |